Peripheral and dual binding site inhibitors of acetylcholinesterase as neurodegenerative disease modifying agents

Author： Dorronsoro Isabel   Castro Ana   Martinez Ana  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.11, 2003-11, pp. : 1725-1732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peripheral and Dual Binding Site Acetylcholinesterase Inhibitors: Implications in treatment of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 3, 2001-09 ,pp. : 267-272

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2818-2836

Bentham Science Publishers

Access to resources Recommend Favorite

From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 960-967

Bentham Science Publishers

Access to resources Recommend Favorite

Acetylcholinesterase Inhibitors as Disease-Modifying Therapies for Alzheimer's Disease

By  

Current Medicinal Chemistry, Vol. 15, Iss. 24, 2008-10 ,pp. : 2433-2455

Bentham Science Publishers

Access to resources Recommend Favorite

Binding Model of Capsaicin is Able to Reach the Peripheral Anionic Site of Acetylcholinesterase

By  

Current Bioactive Compounds, Vol. 13, Iss. 2, 2017-04 ,pp. : 152-156

Bentham Science Publishers

Access to resources Recommend Favorite